Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 5, 2025 • 4:00 PM ET

Date/Time Source News Release
12/20/2024 08:00 AM EST GlobeNewswire Apollomics Announces Top-line Results for Phase 3 Bridging Trial of Uproleselan in China in Patients with Relapsed or Refractory Acute Myeloid Leukemia
12/10/2024 04:05 PM EST GlobeNewswire Apollomics Regains Compliance with Nasdaq's Minimum Bid Price Requirement
11/21/2024 08:00 AM EST GlobeNewswire Apollomics' Announces Shareholder Approval and Effective Date for 1-for-100 Reverse Share Split
09/16/2024 08:00 AM EDT GlobeNewswire Apollomics Presents Vebreltinib Data in Patients with Non-Small Cell Lung Cancer with METex14 Skipping Mutations at European Society for Medical Oncology (ESMO) Congress 2024
09/04/2024 04:05 PM EDT GlobeNewswire Apollomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
08/14/2024 06:00 AM EDT GlobeNewswire Apollomics Reports First Half 2024 Financial Results and Highlights Vebreltinib Clinical Progress
08/13/2024 08:00 AM EDT GlobeNewswire Apollomics Announces Positive Preliminary Data of Vebreltinib in Patients with Non-CNS MET Fusion Solid Tumors from its Phase 2 SPARTA Trial
08/08/2024 04:05 PM EDT GlobeNewswire Apollomics to Present at the Canaccord Genuity 44th Annual Growth Conference
07/16/2024 04:47 PM EDT GlobeNewswire Apollomics Granted 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Requirement
07/03/2024 08:00 AM EDT GlobeNewswire Apollomics Announces Updated Strategic Focus and Leadership Team Changes
Page

Additional News

As of January 5, 2025 • 4:00 PM ET

Date/Time Source News Release
12/31/2024 10:00 PM EST Stock Traders Daily (APLM) Long Term Investment Analysis
12/10/2024 11:06 PM EST Stock Traders Daily How the (APLM) price action is used to our Advantage
11/30/2024 12:38 PM EST Stock Traders Daily When the Price of (APLM) Talks, People Listen
08/14/2024 12:20 PM EDT SeekingAlpha Apollomics GAAP EPS of -$0.38
08/13/2024 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Tue, Aug 13, 2024 as of 4:00 pm ET
08/13/2024 10:49 AM EDT SeekingAlpha Apollomics stock rallies 30% on Phase 2 vebreltinib data
08/13/2024 10:05 AM EDT y%wire Biotech Sees Massive Buying Pressure Following Phase 2 Preliminary Data
08/13/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Tue, Aug 13, 2024 as of 10.00 am ET
07/16/2024 05:31 PM EDT SeekingAlpha Apollomics receives 180-day extension to regain compliance with Nasdaq
07/03/2024 08:26 AM EDT SeekingAlpha Apollomics announces changes in executive leadership team
Page